WGS

GeneDx Holdings Corp. Class A Common Stock

62.37

USD

-1.99

-3.09%

Nov 06, 15:59 UTC -5

Closed

After-Market

63.09

+0.72

+1.15%

GeneDx Holdings Corp. Class A Common Stock (WGS) Profile

GeneDx Holdings Corp. Class A Common Stock Profile

About

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

Info & Links

CEO

Katherine Stueland

Headquarters

333 Ludlow Street, North Tower, 6th Floor
Stamford, CT 06902, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

1,300

GeneDx Holdings Corp. Class A Common Stock Statistics

Valuation Measures

Market Capitalization²

1.88B

Enterprise Value

1.92B

Enterprise Value/EBITDA(ttm)

-29.27

Price to Earnings Ratio(ttm)

178.03

Price to Sales(ttm)

4.21

Price to Book(mrq)

7.83

Price to Cash(ytd)

27.96

Profitability

Gross Margin(ttm)

69.28%

Operating Margin(ttm)

2.49%

Profit Margin(ttm)

-24.64%

Return on Equity(ttm)

4.12%

Return on Invested Capital(ttm)

-30.43%

Return on Assets(ttm)

2.26%

Income Statement

Revenue(ttm)

454.43M

Revenue Per Share(ttm)

15.24

Gross Profit(ttm)

315.24M

EBITDA(ttm)³

-65.53M

Net Income Available to Common(ttm)

-106.36M

Diluted EPS(ttm)

-3.64

Share Statistics

Beta (5Y Monthly)

2.00

52-Week Change

-55.03%

S&P 500 52-Week Change

14.03%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

29.82M

Dividend Yield

0.00%

Float⁴

22.32M

% Held by Insiders

25.17%

% Held by Institutions

61.72%

Balance Sheet

Total Cash(mrq)

132.55M

Total Cash Per Share(mrq)

4.44

Total Debt(mrq)

96.84M

Total Debt/Equity(mrq)

39.65%

Current Ratio(mrq)

3.30%

Quick Ratio(mrq)

3.06%

Book Value Per Share(mrq)

8.19

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.07

Free Cash Flow(ytd)

-77.96M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.